Aldosterone synthesis in the brain contributes to Dahl salt-sensitive rat hypertension

Experimental Physiology

Volumn 95, Issue 1, 2010, Pages 120-130

  Gomez Sanchez, Elise P ^a,b   Gomez Sanchez, Clara M ^a   Plonczynski, Maria ^a   Gomez Sanchez, Celso E ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; ALDOSTERONE; ALDOSTERONE SYNTHASE; ANTIHYPERTENSIVE AGENT; CORTICOSTERONE; FAD 286; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; OXYGENASE INHIBITOR; STEROID 11BETA MONOOXYGENASE; UNCLASSIFIED DRUG;

ADRENAL GLAND; ALDOSTERONE SYNTHESIS; ALDOSTERONE URINE LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN LEVEL; CONTINUOUS INFUSION; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; DRUG DOSE COMPARISON; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SPECIFICITY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HORMONE DETERMINATION; HORMONE SYNTHESIS; HYPERTENSION; MALE; NONHUMAN; PROVOCATION TEST; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALT INTAKE; SPRAGUE DAWLEY RAT; STRAIN DIFFERENCE; TISSUE LEVEL;

EID: 74049102379     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2009.048900     Document Type: Article

References (77)

1. Abayasekara DR, Onyezili NI, Whitehouse BJ, Laird SM Vinson GP (1993). Effects of chronic corticotrophin treatment on aldosterone metabolism in the rat. J Endocrinol 137, 445 455.
2. Atanasov AG, Nashev LG, Schweizer RA, Frick C Odermatt A (2004). Hexose-6-phosphate dehydrogenase determines the reaction direction of 11β-hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Lett 571, 129 133.
3. Baba K, Mulrow PJ, Franco-Saenz R Rapp JP (1986). Suppression of adrenal renin in Dahl salt-sensitive rats. Hypertension 8, 1149 1153. (Pubitemid 17228786)
4. Banhegyi G, Benedetti A, Fulceri R Senesi S (2004). Cooperativity between 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum. J Biol Chem 279, 27017 27021.
5. Birmingham MD, Stumpf WE Sar M (1979). Nuclear Iocalization of aldosterone in rat brain cells assessed by autoradiography. Experientia 35, 1240 1241.
6. Bitran D, Shiekh M, Dowd JA, Dugan MM Renda P (1998). Corticosterone is permissive to the anxiolytic effect that results from the blockade of hippocampal mineralocorticoid receptors. Pharmacol Biochem Behav 60, 879 887.
7. Brody MJ, Varner KJ, Vasquez EC Lewis SJ (1991). Central nervous system and the pathogenesis of hypertension. Sites and mechanisms. Hypertension 18, III7 III12.
8. Carey RM, Douglas JG, Schweikert JR Liddle GW (1972). The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone. Arch Intern Med 130, 849 854.
9. Cicila GT, Rapp JP, Wang J-M, St Lezin E, Ng SC Kurtz TW (1993). Linkage of 11β-hydroxylase mutations with altered steroid biosynthesis and blood pressure in the Dahl rat. Nat Genet 3, 346 353.
10. Cover CM, Wang J, St Lezin E, Kurtz TW Mellon SH (1995). Molecular variants in the P450c11AS gene as determinants of aldosterone synthase activity in the Dahl rat model of hypertension. J Biol Chem 270, 16555 16560.
11. Davson H Segal MB (1996). Physiology of the CSF and Blood-Brain Barriers. CRC Press, Boca Ratan, FL, USA.
12. De Kloet ER, Van Acker SA, Sibug RM, Oitzl MS, Meijer OC, Rahmouni K de Jong W (2000). Brain mineralocorticoid receptors and centrally regulated functions. Kidney Int 57, 1329 1336.
13. De Kloet ER, Versteeg DHG Kovacs GL (1983). Aldosterone blocks the response to corticosterone in the raphe-hippocampal serotonin system. Brain Res 264, 323 327.
14. Fiebeler A, Nussberger J, Shagdarsuren E, Rong S, Hilfenhaus G, Al-Saadi N, Dechend R, Wellner M, Meiners S, Maser-Gluth C, Jeng AY, Webb RL, Luft FC Muller DN (2005). Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage. Circulation 111, 3087 3094. (Pubitemid 40847786)
15. Geerling JC, Kawata M Loewy AD (2006). Aldosterone-sensitive neurons in the rat central nervous system. J Comp Neurol 494, 515 527.
16. Geerling JC, Sequeira SM Loewy AD (2005). Increased number of aldosterone-sensitive NTS neurons in Dahl salt-sensitive rats. Brain Res 1065, 142 146.
17. Ginn DI, Baptista CA, Alam KY, Deng AY, Cicila GT, Margolius HS Rapp JP (1993). Estimate of the genetic divergence between inbred Dahl salt-sensitive and salt-resistant rats. J Hypertens 11, 477 481.
18. Gomez-Sanchez CE, Bataillard A, Vincent M Sassard J (1987a). Urinary mineralocorticoids in genetically hypertensive rats of the Lyon strain. J Hypertension 5 (Suppl 5 S227 S229.
19. Gomez-Sanchez CE, de Rodriguez AF, Romero DG, Estess J, Warden MP, Gomez-Sanchez MT Gomez-Sanchez EP (2006). Development of a panel of monoclonal antibodies against the mineralocorticoid receptor. Endocrinology 147, 1343 1348.
20. Gomez-Sanchez CE, Foecking MF, Ferris MW, Chavarri MR, Uribe L Gomez-Sanchez EP (1987b). The production of monoclonal antibodies against aldosterone. Steroids 49, 581 587.
21. Gomez-Sanchez CE Gomez-Sanchez EP (2001). Role of central mineralocorticoid receptors in cardiovascular disease. Curr Hypertens Rep 3, 263 269.
22. Gomez-Sanchez CE, Holland OB, Higgins JR, Kem DC Kaplan NM (1976). Circadian rhythms of serum renin activity and serum corticosterone, prolactin, and aldosterone concentrations in the rat during normal and low sodium diet. Endocrinology 99, 567 572.
23. Gomez-Sanchez CE, Zhou MY, Cozza EN, Morita H, Eddleman FC Gomez-Sanchez EP (1996). Corticosteroid synthesis in the central nervous system. Endocr Res 22, 463 470.
24. Gomez-Sanchez CE, Zhou MY, Cozza EN, Morita H, Foecking MF Gomez-Sanchez EP (1997). Aldosterone biosynthesis in the rat brain. Endocrinology 138, 3369 3373.
25. Gomez-Sanchez EP (1986). Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology 118, 819 823.
26. Gomez-Sanchez EP (1994). Hypertension and the mineralocorticoid receptor in the brain. Ann NY Acad Sci 746, 415 417.
27. Gomez-Sanchez EP (2004). Brain mineralocorticoid receptors: orchestrators of hypertension and end-organ disease. Curr Opin Nephrol Hypertens 13, 191 196.
28. Gomez-Sanchez EP, Ahmad N, Romero DG Gomez-Sanchez CE (2004). Origin of aldosterone in the rat heart. Endocrinology 145, 4796 4802.
29. Gomez-Sanchez EP, Ahmad N, Romero DG Gomez-Sanchez CE (2005a). Is aldosterone synthesized within the rat brain? Am J Physiol Endocrinol Metab 288, E342 E346.
30. Gomez-Sanchez EP, Fort C Thwaites D (1992). Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats. Am J Physiol Endocrinol Metab 262, E96 E99.
31. Gomez-Sanchez EP, Fort CM Gomez-Sanchez CE (1990a). Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension. Am J Physiol Endocrinol Metab 258, E482 E484.
32. Gomez-Sanchez EP, Ganjam V, Chen YJ, Liu Y, Zhou MY, Toroslu C, Romero DG, Hughson MD, de Rodriguez A Gomez-Sanchez CE (2003). Regulation of 11β-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol. Am J Physiol Endocrinol Metab 285, E272 E279.
33. Gomez-Sanchez EP Gomez-Sanchez CE (1988). 19-Nordeoxycorticosterone excretion in male and female inbred salt-sensitive (S/JR) and salt-resistant (R/JR) rats. Endocrinology 122, 1110 1113.
34. Gomez-Sanchez EP Gomez-Sanchez CE (1991a). 19-Nordeoxycorticosterone, aldosterone and corticosterone excretion in sequential urine samples of male and female rats. Steroids 56, 451 454.
35. Gomez-Sanchez EP Gomez-Sanchez CE (1991b). The effect of gonadectomy and aromatase inhibition on the excretion of 19-nordeoxycorticosterone in rats. J Steroid Biochem Mol Biol 39, 185 188.
36. Gomez-Sanchez EP Gomez-Sanchez CE (1994). Effect of central amiloride infusion on mineralocorticoid hypertension. Am J Physiol Endocrinol Metab 267, E754 E758.
37. Gomez-Sanchez EP Gomez-Sanchez CE (1995). The effect of the central infusion of benzamil on Dahl S rat hypertension. Am J Physiol Heart Circ Physiol 269, H1044 H1047.
38. Gomez-Sanchez EP Gomez-Sanchez CE (1997). Editorial: First there was one, then two... why more 11β-hydroxysteroid dehydrogenases? Endocrinology 138, 5087 5088.
39. Gomez-Sanchez EP Gomez-Sanchez CE (1999). Maternal hypertension and progeny blood pressure: role of aldosterone and 11β-HSD. Hypertension 33, 1369 1373.
40. Gomez-Sanchez EP, Gomez-Sanchez MT, de Rodriguez AF, Romero DG, Warden MP, Plonczynski MW Gomez-Sanchez CE (2009). Immunohistochemical demonstration of the mineralocorticoid receptor, 11β-hydroxysteroid dehydrogenase-1 and -2, and hexose-6-phosphate dehydrogenase in rat ovary. J Histochem Cytochem 57, 633 641.
41. Gomez-Sanchez EP, Romero DG, de Rodriguez AF, Warden MP, Krozowski Z Gomez-Sanchez CE (2008). Hexose-6-phosphate dehydrogenase and 11β-hydroxysteroid dehydrogenase-1 tissue distribution in the rat. Endocrinology 149, 525 533.
42. Gomez-Sanchez EP, Samuel J, Vergara G Ahmad N (2005b). Effect of 3β-hydroxysteroid dehydrogenase inhibition by trilostane on blood pressure in the Dahl salt-sensitive rat. Am J Physiol Regul Integr Comp Physiol 288, R389 R393.
43. Gomez-Sanchez EP, Venkataraman MT Thwaites D (1990b). ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am J Physiol Endocrinol Metab 258, E649 E653.
44. Goto A, Ikeda T, Tobian L, Iwai J Johnson MA (1981). Brain lesions in the paraventricular nuclei and catecholaminergic neurons minimize salt hypertension in Dahl salt-sensitive rats. Clin Sci 61, 53s-55s.
45. Huang BS, Cheung WJ, Wang H, Tan J, White RA Leenen FH (2006). Activation of brain renin-angiotensin-aldosterone system by central sodium in Wistar rats. Am J Physiol Heart Circ Physiol 291, H1109 H1117.
46. + channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI. Am J Physiol Heart Circ Physiol 288, H2491 H2497.
47. +] precede the increases in blood pressure in Dahl S rats and SHR on a high-salt diet. Am J Physiol Heart Circ Physiol 287, H1160 H1166.
48. Huang BS, Wang H Leenen FH (2005). Chronic central infusion of aldosterone leads to sympathetic hyperreactivity and hypertension in Dahl S but not Dahl R rats. Am J Physiol Heart Circ Physiol 288, H517 H524.
49. + in Wistar rats. Am J Physiol Regul Integr Comp Physiol 295, R166 R172.
50. Huang BS, White RA, Ahmad M, Tan J, Jeng AY Leenen FH (2009a). Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction. Cardiovasc Res 81, 574 581.
51. Huang BS, White RA, Jeng AY Leenen FH (2009b). Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 296, R994 R1000.
52. Janiak P Brody MJ (1988). Central interactions between aldosterone and vasopressin on cardiovascular system. Am J Physiol Regul Integr Comp Physiol 255, R166 R173.
53. Janiak PC, Lewis SJ Brody MJ (1990). Role of central mineralocorticoid binding sites in development of hypertension. Am J Physiol Regul Integr Comp Physiol 259, R1025 R1034.
54. Lassman MN Mulrow PJ (1974). Deficiency of deoxycorticosterone-binding protein in the hypothalamus of rats resistant to deoxycorticosterone induced hypertension. Endocrinology 94, 1541 1546.
55. Lloyd-MacGilp SA, Torielli L, Bechtel S, Tripodi G, Gomez-Sanchez CE, Zagato L, Bernhardt R Kenyon CJ (2002). Mutations in aldosterone synthase gene of Milan hypertensive rats: phenotypic consequences. Am J Physiol Endocrinol Metab 282, E608 E617.
56. London GM, Safar ME, Weiss YA, Corvol PL, Menard JE, Simon AC Milliez PL (1977). Relationship of plasma renin activity and aldosterone levels with hemodynamic functions in essential hypertension. Arch Intern Med 137, 1042 1047.
57. MacKenzie SM, Clark CJ, Fraser R, Gomez-Sanchez CE, Connell JMC Davies E (2000). Expression of 11β-hydroxylase and aldosterone synthase genes in rat brain. J Mol Endocrinol 24, 321 328.
58. MacKenzie SM, Lai M, Clark CJ, Fraser R, Gomez-Sanchez CE, Seckl JR, Connell JM Davies E (2002). 11β-Hydroxylase and aldosterone synthase expression in fetal rat hippocampal neurons. J Mol Endocrinol 29, 319 325.
59. Mark AL (1991). Sympathetic neural contribution to salt-induced hypertension in Dahl rats. [Review]. Hypertension 17, I86 I90.
60. Mellon SH (1994). Neurosteroids: biochemistry, modes of action and clinical relevance. J Clin Endocrinol Metab 78, 1003 1008.
61. Pacha J Pohlova I (1993). The influence of high salt intake on intestinal Na,K-ATPase in Wistar and Dahl rats. Acta Physiol Scand 148, 69 75.
62. Pitt B (2004). Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies. Mol Cell Endocrinol 217, 53 58.
63. Rapp JP, Tan SY Margolius HS (1978). Plasma mineralocorticoids, plasma renin, and urinary kallikrein in salt-sensitive and salt-resistant rats. Endocr Res Commun 5, 35 41.
64. Reul JMH De Kloet ER (1985). Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117, 2505 2511.
65. Roland BL Funder JW (1996). Localization of 11β-hydroxysteroid dehydrogenase type 2 in rat tissues: in situ studies. Endocrinology 137, 1123 1128.
66. Seckl JR Walker BR (2001). Minireview: 11β-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action. Endocrinology 142, 1371 1376.
67. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CHL Edwards CRW (1987). Mineralocorticoid activity of liquorice: 11-β-hydroxysteroid dehydrogenase deficiency comes of age. Lancet ii, 821 824.
68. Stromstedt M Waterman MR (1995). Messenger RNAs encoding steroidogenic enzymes are expressed in rodent brain. Brain Res Mol Brain Res 34, 75 88.
69. Takata Y, Yamashita Y, Takishita S Fujishima M (1988). Lack of increase in sodium concentration of cerebrospinal fluid in DOCA-salt hypertensive rats. Am J Hypertens 1, 45S 48S.
70. Takeshita A, Mark AL Brody MJ (1979). Prevention of salt-induced hypertension in Dahl strain by 6-hydroxydopamine. Am J Physiol Heart Circ Physiol 236, H48 H52.
71. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M Stewart PM (2004). 11β-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25, 831 866.
72. Tsutamoto T, Wada A, Maeda K, Hayashi M, Tsutsui T, Ohnishi M, Fujii M, Matsumoto T, Yamamoto T, Takayama T Ishii C (2003). Transcardiac gradient of aldosterone before and after spironolactone in patients with congestive heart failure. J Cardiovasc Pharmacol 41, S19 S22.
73. Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Horie H, Sugimoto Y Kinoshita M (2000). Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure. J Am Coll Cardiol 36, 838 844.
74. Wright I, Upton N Marsden C (1992). Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behavior on the elevated X-maze. Psychopharmacology 109, 338 346.
75. Ye P, Nakamura Y, Lalli E Rainey WE (2009). Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells. Endocrinology 150, 1303 1309.
76. Yu L, Romero DG, Gomez-Sanchez CE Gomez-Sanchez EP (2002). Steroidogenic enzyme gene expression in the human brain. Mol Cell Endocrinol 190, 9 17.
77. Yu Y, Wei SG, Zhang ZH, Gomez-Sanchez E, Weiss RM Felder RB (2008). Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure? Hypertension 51, 727 733. (Pubitemid 351301527)